Global Lancing Devices Market Overview And Scope:
Global Lancing Devices Market Size was estimated at USD 335.4 million in 2022 and is projected to reach USD 441.9 million by 2028, exhibiting a CAGR of 4.7% during the forecast period.
The Global Lancing Devices Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Lancing Devices utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Abbott, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, GMMC Group, ARKRAY, GMMC Group, BIONIME, LIANFA, Lobeck Medical AG
Global Lancing Devices Market Segmentation
By Type, Lancing Devices market has been segmented into:
Adjustable Lancing Device
Non-adjustable Lancing Device
By Application, Lancing Devices market has been segmented into:
Glucose Tests
Cholesterol Tests
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Lancing Devices market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Lancing Devices market.
Top Key Players Covered in Lancing Devices market are:
Abbott
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
GMMC Group
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG
Objective to buy this Report:
1. Lancing Devices analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Lancing Devices market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Lancing Devices Market by Type
5.1 Lancing Devices Market Overview Snapshot and Growth Engine
5.2 Lancing Devices Market Overview
5.3 Adjustable Lancing Device
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Adjustable Lancing Device: Geographic Segmentation
5.4 Non-adjustable Lancing Device
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Non-adjustable Lancing Device: Geographic Segmentation
Chapter 6: Lancing Devices Market by Application
6.1 Lancing Devices Market Overview Snapshot and Growth Engine
6.2 Lancing Devices Market Overview
6.3 Glucose Tests
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Glucose Tests: Geographic Segmentation
6.4 Cholesterol Tests
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Cholesterol Tests: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Lancing Devices Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Lancing Devices Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Lancing Devices Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ABBOTT
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 LIFESCAN
7.4 ABBOTT
7.5 ASCENSIA
7.6 B. BRAUN
7.7 TERUMO
7.8 GMMC GROUP
7.9 ARKRAY
7.10 GMMC GROUP
7.11 BIONIME
7.12 LIANFA
7.13 LOBECK MEDICAL AG
Chapter 8: Global Lancing Devices Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Adjustable Lancing Device
8.2.2 Non-adjustable Lancing Device
8.3 Historic and Forecasted Market Size By Application
8.3.1 Glucose Tests
8.3.2 Cholesterol Tests
8.3.3 Others
Chapter 9: North America Lancing Devices Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Adjustable Lancing Device
9.4.2 Non-adjustable Lancing Device
9.5 Historic and Forecasted Market Size By Application
9.5.1 Glucose Tests
9.5.2 Cholesterol Tests
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Lancing Devices Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Adjustable Lancing Device
10.4.2 Non-adjustable Lancing Device
10.5 Historic and Forecasted Market Size By Application
10.5.1 Glucose Tests
10.5.2 Cholesterol Tests
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Lancing Devices Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Adjustable Lancing Device
11.4.2 Non-adjustable Lancing Device
11.5 Historic and Forecasted Market Size By Application
11.5.1 Glucose Tests
11.5.2 Cholesterol Tests
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Lancing Devices Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Adjustable Lancing Device
12.4.2 Non-adjustable Lancing Device
12.5 Historic and Forecasted Market Size By Application
12.5.1 Glucose Tests
12.5.2 Cholesterol Tests
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Lancing Devices Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Adjustable Lancing Device
13.4.2 Non-adjustable Lancing Device
13.5 Historic and Forecasted Market Size By Application
13.5.1 Glucose Tests
13.5.2 Cholesterol Tests
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Lancing Devices Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Adjustable Lancing Device
14.4.2 Non-adjustable Lancing Device
14.5 Historic and Forecasted Market Size By Application
14.5.1 Glucose Tests
14.5.2 Cholesterol Tests
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Lancing Devices Scope:
|
Report Data
|
Lancing Devices Market
|
|
Lancing Devices Market Size in 2025
|
USD XX million
|
|
Lancing Devices CAGR 2025 - 2032
|
XX%
|
|
Lancing Devices Base Year
|
2024
|
|
Lancing Devices Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, GMMC Group, ARKRAY, GMMC Group, BIONIME, LIANFA, Lobeck Medical AG.
|
|
Key Segments
|
By Type
Adjustable Lancing Device
Non-adjustable Lancing Device
By Applications
Glucose Tests
Cholesterol Tests
Others
|
